PAPRIKA - Patients Empowerment for Major Surgery Preparation @Home (PAPRIKA)

March 3, 2020 updated by: Anael Barberan-Garcia, Hospital Clinic of Barcelona

PAPRIKA establishes a technologically enabled and personalized prehabilitation and follow-up after surgical intervention program for patients undergoing elective major surgery Program creates close collaboration between the medical environment and the patients empowering them to co-create their own care.

It is at the first stage aimed to high-risk patients undergoing major surgery. Better condition before the surgery is proved to reduce the perioperative complications and to improve patients' health-related quality of life while cutting the associated costs. The concept integrates short-term (average 4 weeks) preoperative interventions including endurance training, promotion of physical activity and nutritional and psychological support. Interventions are planned both at community and at hospital reducing unnecessary interactions between patients and tertiary care.

PAPRIKA tackles three major drivers: i) human perspective ii) organizational challenges and iii) technical aspects. The project is based on previous experience on prehabilitation and the already refined service using design thinking methodologies. It will be also based on the proven reduction of associated costs for the healthcare system.

Study Overview

Study Type

Observational

Enrollment (Anticipated)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Catalonia
      • Barcelona, Catalonia, Spain, 08036
        • Recruiting
        • Hospital Clínic de Barcelona

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Prospective sample of risk patients who are candidates for major surgery attended in the outpatient offices of the Hospital Clínic de Barcelona.

Description

Inclusion Criteria:

  • Age > 70 years old and/or American Society of Anesthesiologist (ASA) index 3-4 and/or highly aggressive surgery or solid organ transplantation.

Exclusion Criteria:

  • Non-elective surgery; metastatic disease.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Usual care
A contemporaneous control group of patients was build using propensity score matching (PSM) methodologies taking into account the following matching variables: type of surgery, age, sex, American Society of Anesthesiologists Index (ASA) and adjusted morbidity groups (GMA) grading.
The preoperative standard measures consist of physical activity recommendation and advice on both smoking cessation and alcohol intake reduction. Moreover, in patients presenting with anemia, the anesthesiologists will assess its etiology and treat it accordingly, and nutritional intervention will be performed by a registered dietitian in to those patients at risk of malnutrition (Malnutrition Universal Screening Tool ≥2).
Prehabilitation

Prospective sample of risk patients who are candidates for major surgery attended in the outpatient offices of the Hospital Clínic de Barcelona.

Inclusion criteria: i) American Society of Anesthesiologists Index (ASA) 3-4; and / or, ii) age ≥ 75 years; and / or iii) major aggressive surgery; and, iv) solid organ transplant candidate.

Exclusion criteria: i) Non-elective surgery; ii) Known metastatic disease before surgery; iii) Unstable respiratory or heart disease; or, iv) Locomotive or cognitive limitations that prevent adherence to the program.

i) Exercise training: Ambulatory exercise training sessions with two main components, namely: high-intensity endurance exercise training and strength muscular training.

ii) Promotion of physical activity: Pedometer-based program using a physical activity tracker linked to a mobile app.

iv) Nutritional optimization: Recommendations of a healthy balanced diet or adapted to their digestive symptoms. Daily amount of protein intake will be close to 2 g•Kg-1•day-1.

iv) Smoking cessation: Use of both cognitive behavioral intervention and pharmacological therapy by varenicline or nicotine replacement therapies.

v) Cognitive behavioral therapy: Weekly group sessions conducted by a clinical health psychologist, including psychoeducation, motivational and behavioral change, self-efficacy and adherence enhancement, coping strategies acquisition and patient empowerment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative complications
Time Frame: Duration of the initial hospitalization for surgery
Number of postoperative complications during the initial hospitalization for surgery
Duration of the initial hospitalization for surgery
Hospital length of stay
Time Frame: Duration of the initial hospitalization for surgery
Number of days of hospital length of stay during the initial hospitalization for surgery
Duration of the initial hospitalization for surgery
Severity of postoperative complications
Time Frame: Duration of the initial hospitalization for surgery
Severity of postoperative complications during the initial hospitalization for surgery using the Clavien-Dindo classification
Duration of the initial hospitalization for surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hospital readmissions at 30 days
Time Frame: From initial hospital discharge to 30 days follow-up
Number of postoperative complications during a 30-day period after surgery
From initial hospital discharge to 30 days follow-up
Emergency room visits at 30 days
Time Frame: From initial hospital discharge to 30 days follow-up
Number of emergency room visits during a 30-day period after surgery
From initial hospital discharge to 30 days follow-up
Surgical reinterventions at 30 days
Time Frame: From initial hospital discharge to 30 days follow-up
Number of surgical reinterventions during a 30-day period after surgery
From initial hospital discharge to 30 days follow-up
Mortality at 30 days
Time Frame: From initial hospital discharge to 30 days follow-up
Number of exitus during a 30-day period after surgery
From initial hospital discharge to 30 days follow-up

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Six-minute walk test
Time Frame: At program inclusion and at program discharge (on average at 6 weeks)
Distance covered during the six-minute walk test
At program inclusion and at program discharge (on average at 6 weeks)
Physical activity
Time Frame: At program inclusion and at program discharge (on average at 6 weeks)
Physical activity measured by the Yale Physical Activity Survey (YPAS) (range 0 to 142; the lowest the worst)
At program inclusion and at program discharge (on average at 6 weeks)
Psycho-emotional status
Time Frame: At program inclusion and at program discharge (on average at 6 weeks)
Psycho-emotional status measured by the Hospital Anxiety and Depression (HAD) scale (range 0-21; the highest the worst)
At program inclusion and at program discharge (on average at 6 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Josep Roca, Prof, Hospital Clinic of Barcelona

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 1, 2020

Primary Completion (ANTICIPATED)

June 30, 2020

Study Completion (ANTICIPATED)

July 30, 2020

Study Registration Dates

First Submitted

February 27, 2020

First Submitted That Met QC Criteria

March 3, 2020

First Posted (ACTUAL)

March 4, 2020

Study Record Updates

Last Update Posted (ACTUAL)

March 4, 2020

Last Update Submitted That Met QC Criteria

March 3, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Clinical Trials on Usual care

3
Subscribe